Adiponectin, an adipocyte protein important in insulin sensitization and cardioprotection, has a strong genetic component. We hypothesized that variants in the adiponectin gene (adipocyte collagen-domain containing [ACDC]) contribute to adiponectin levels in a biracial adolescent cohort. We genotyped 11 ACDC single nucleotide polymorphisms (SNPs) in 631 non-Hispanic white and 553 AfricanAmerican unrelated adolescents in grades 5-12 randomly selected from the Princeton School District Study. ACDC SNPs ؊11,391 (A allele), ؊10,068 (G allele), and ؉276 (T allele) were associated with higher adiponectin, adjusting for sex, puberty stage, BMI Z score, and waist Z score. Contiguous two-SNP haplotypes of promoter variants ؊11,391/؊10,068 were significantly associated with adiponectin levels in whites and African Americans (P < 0.0001 and 0.03, respectively). Extended haplotypes from the promoter through the second intron (؊11,391 to ؉349) strongly associated with adiponectin in whites (P ‫؍‬ 6 ؋ 10 ؊11 ) and African Americans (P ‫؍‬ 0.004), but haplotypes of first intron SNPs ؊4,521 to ؊657 did not (P > 0.2). Noncontiguous haplotypes or interactions between two-SNP (؊11,391/؊10,068) and three-SNP (؉45, ؉276, and ؉349) haplotypes predicted adiponectin better than either region alone. Variants of ACDC are associated with adiponectin levels in whites and African Americans. Interactions between noncontiguous ACDC haplotypes strongly influence adiponectin levels, suggesting nonadditive and potentially cis relationships between these regions. Diabetes 55: [523][524][525][526][527][528][529] 2006 A diponectin is an abundant adipocyte-derived protein that has important roles in insulin sensitization, cardioprotection, and anti-inflammatory processes. Low adiponectin levels have been associated with the development of several cardiovascular end points, including myocardial infarction and hypertension (1,2), and may also have direct cardioprotective effects on vascular tissue (3-5). In addition, low adiponectin levels are associated with poor plasma lipid profiles in adults and children (6 -8) and precede insulin resistance and type 2 diabetes (9 -11).
A
diponectin is an abundant adipocyte-derived protein that has important roles in insulin sensitization, cardioprotection, and anti-inflammatory processes. Low adiponectin levels have been associated with the development of several cardiovascular end points, including myocardial infarction and hypertension (1, 2) , and may also have direct cardioprotective effects on vascular tissue (3) (4) (5) . In addition, low adiponectin levels are associated with poor plasma lipid profiles in adults and children (6 -8) and precede insulin resistance and type 2 diabetes (9 -11) .
Adiponectin levels have a strong genetic component, with heritability estimated between 30 and 50% (12, 13) . The adiponectin protein is coded by the gene named adipocyte collagen-domain containing (ACDC). Linkage studies of adiponectin level have reported linkage peaks at the ACDC locus at chromosome 3q27 (14, 15) , which are reduced by the inclusion of ACDC SNPs in the linkage model (15) . SNPs and haplotypes in ACDC are associated with adiponectin level (16, 17) , and some ACDC SNPs affect adiponectin expression or secretion (18, 19) . However, conflicting association results in various populations suggest a complex relationship between ACDC variation and phenotypic adiponectin levels.
Adiponectin levels are typically lower in African Americans than whites (20, 21) . Few studies have explored the genetic basis for adiponectin levels in African Americans. One genome scan in African Americans found high heritability for adiponectin levels (h 2 ϭ 0.82) but no evidence of linkage near the ACDC locus (22) . To date, only one study has reported on ACDC SNPs in African Americans in association with body fat and plasma lipids (23) . Our objective, therefore, was to use a large, school-based cohort of adolescents to explore the associations of ACDC SNPs with adiponectin levels in non-Hispanic whites and African Americans.
participants Ͼ18 years old and parents/guardian for those Ͻ18 years provided written informed consent, and individuals Ͻ18 years provided written assent. Laboratory measurements. Plasma adiponectin levels were measured in duplicate using radioimmunoassay (Linco, St. Louis, MO), with a sensitivity of 0.5 g/ml and intra-and interassay coefficients of variation of 5 and 15%, respectively. Puberty staging. Pubertal status determination was described previously (24) . Briefly, sex hormone cut points for testosterone and estradiol were established to distinguish prepuberty (Tanner I) from puberty (Tanner II-IV) using data from two large Cincinnati-based cohorts with full Tanner staging. Postpuberty was defined in girls with menarche duration Ն2 years and in boys with an adult distribution of axillary hair. Calculated variables. BMI Z scores for age and sex were determined based on Centers for Disease Control and Prevention growth charts (27) . Because nationally representative waist Z scores are not available, waist Z scores using age-and sex-specific means and standard deviations were derived from our cohort (n ϭ 1,196). SNP selection and genotyping. Eleven SNPs were selected to span the adiponectin gene ACDC, including several SNPs reported to be associated with adiponectin levels or metabolic phenotypes in other populations (16,17,28 -30) . We particularly focused on SNPs with a minor allele frequency Ͼ10%, although this was not achieved in all cases.
Blood samples were stored on wet ice immediately after collection, and buffy coats were stored at Ϫ80°C until processing. DNA was extracted using Gentra Puregene kits, and most SNPs were genotyped using TaqMan. Plates were read using an ABI 7900 machine with automatic allele calling, supplemented as necessary with manual allele calling, especially for SNPs of low minor allele frequency (Ͻ0.05). SNP ϩ45 was genotyped using a PCR-based restriction fragment-length polymorphism protocol described by Zeitz et al. (31) . Details about sample processing and genotyping protocols are included in Supplemental Table 1 , which is detailed in the online appendix (available at http://diabetes.diabetesjournals.org). Statistical analyses. Analyses were conducted using SAS version 9.1 (Cary, NC) and Haplo.Stats version 1.2.0 (32). Continuous variables were analyzed for normality. Natural log transformations did not improve statistical deviations from normality in our large sample, so all variables were analyzed in original units. Genetic analyses. All genetic analyses were conducted in whites and African Americans separately. Hardy-Weinberg equilibrium (HWE) was tested for each SNP, and linkage disequilibrium among SNPs was inferred using the Haploview (33) and EMLD programs (34) . Haplotypes were estimated using the Haplo.Stats program. Contiguous haplotypes of arbitrary size were examined for global association with adiponectin level using Haplo.Stats, with the haplotype combination with the smallest global P value chosen.
Two different sections of the ACDC gene, the promoter and coding regions, have previously been reported as associated with adiponectin levels. Therefore, the relative contributions of these two physically distant regions of the ACDC gene to adiponectin levels were explored. Extended haplotypes of multiple SNPs spanning the gene were subdivided based on the linkage disequilibrium structure of the gene and the physical location of the SNPs within the gene. Thus, haplotypes from three different regions of ACDC (e.g., promoter, first intron, and coding region/second intron) were estimated.
These regional haplotypes were examined for association with adiponectin level individually and jointly. In addition, an interaction between the promoter and coding region/second intron haplotypes was specifically considered by creating a "noncontiguous " haplotype excluding SNPs in the first intron. Linear regression, including genetic data. SNPs were analyzed separately in whites and African Americans using SAS. All results are reported adjusting for sex, puberty stage, BMI Z score, and waist Z score, although very similar results were seen in unadjusted analyses (data not shown). All SNPs were analyzed under an additive genetic model, using a single variable coding homozygous wild types as ϩ1, heterozygotes as 0, and homozygous variants as Ϫ1, which, when analyzed as a continuous variable, tests the linear trend in adiponectin by genotype. Genotype-specific Bonferroni-adjusted least squares means and 95% CIs were generated using general linear modeling, modeling genotype categorically. Because 11 SNPs were analyzed, a Bonferroni multiple correction was also applied across SNPs, which is conservative because it does not account for correlated SNP data. Thus, a P value of 0.0045 for each SNP-level association (Table 2 ) was considered significant after this correction.
Individual-level haplotype combinations were weighted with their Bayesian posterior probability from Haplo.Stats (determined separately by race) and included in linear regression models in SAS. To compare non-nested models of different haplotype combinations, only individuals with a posterior probability of 0.50 or more for all haplotypes of interest and full data for the component SNPs were included (n ϭ 559 whites and 498 African Americans). Interactions between gene region-specific haplotypes were modeled by multiplying the posterior probabilities of two haplotypes. Models were arranged by adjusted R 2 , and non-nested models were evaluated using the Bayesian information criterion (BIC). The model with the lowest BIC value was selected. BIC differences Ͼ10 indicate "very strong" evidence in favor of the model with the smaller BIC (35) . Multicollinearity among variables within the same model was evaluated using variance inflation factors, with variance inflation factor Յ4.0 acceptably independent. Data are presented as least squares mean (95% CI) or ␤ Ϯ SE, with P values Յ0.05 considered significant.
RESULTS
The 11 ACDC SNPs satisfied HWE assumptions, except SNP Ϫ4,041 in African Americans (P Ͻ 0.0001), which was eliminated from further analysis in that group. SNP ϩ45 was somewhat out of HWE in whites (P ϭ 0.03) but was retained in the analysis because of its previous associations with metabolic outcomes. In addition, this finding may be due to chance, because after Bonferroni correction, this deviation from HWE was no longer significant. Allele frequencies differed significantly by race (Table 1) , except for SNPs Ϫ10,068 and Ϫ657. Linkage disequilibrium was strong in the coding region/second intron in whites and African Americans (Supplemental Table 2 , which is detailed in the online appendix). Whites also showed strong linkage disequilibrium in the 5Ј promoter region, which was attenuated in African Americans. Adiponectin SNPs are associated with adiponectin level. Among whites, the SNP Ϫ11,391 A allele (P ϭ 0.002), Ϫ10,068 G allele (P ϭ 0.03), and ϩ276 T allele (P ϭ 0.05) were associated with higher adiponectin levels in adjusted analyses (Table 2) . In African Americans, the SNP Ϫ11,391 A allele (P ϭ 0.11) and ϩ276 T allele (P ϭ 0.03) were also marginally or significantly associated with higher adiponectin level. After conservatively correcting for multiple comparisons, only the association between SNP Ϫ11,391 A allele in whites remained significant. Haplotypes of promoter and coding region/second intron SNPs are associated with adiponectin level.
Haplotypes of SNPs Ϫ11,391 and Ϫ10,068 (two-SNP haplotypes) were associated with adiponectin level in whites and African Americans (global P ϭ 2 ϫ 10 Ϫ5 and 0.03, respectively). In adjusted regression analyses, the A/G haplotype was associated with higher adiponectin levels compared with the other two-SNP haplotypes in whites (␤ Ϯ SE ϭ 1.7 Ϯ 0.4 g/ml, P Ͻ 0.0001) and African Americans (␤ Ϯ SE ϭ 1.7 Ϯ 1.0 g/ml, P ϭ 0.09).
Haplotypes of the coding region/second intron SNPs ϩ45, ϩ276, and ϩ349 (three-SNP haplotypes) were associated with adiponectin level in whites but not in African Americans (global P ϭ 0.001 and 0.4, respectively). In whites, the three-SNP haplotype combinations T/T/A (␤ Ϯ SE ϭ 0.66 Ϯ 0.3 g/ml, P ϭ 0.04) and T/G/G (␤ Ϯ SE ϭ 1.4 Ϯ 0.6 g/ml, P ϭ 0.02) were associated with higher adiponectin in adjusted analyses.
Contiguous haplotypes encompassing SNPs from the promoter through the second intron, however, were best associated with adiponectin levels in whites (global P ϭ 6 ϫ 10 Ϫ11 for SNPs Ϫ11,391 to ϩ349) and African Ameri- cans (global P ϭ 0.004 for SNPs Ϫ11,391 to ϩ45). For consistency, the extended haplotype Ϫ11,391 to ϩ349 was analyzed in whites and African Americans.
Interactions between promoter and coding region/ second intron haplotypes significantly impact adiponectin levels. To explore the critical regions of the extended haplotype, we divided this haplotype into three sections based on linkage disequilibrium structure and physical location of SNPs in the gene: 1) promoter SNPs Ϫ11,391/Ϫ10,068 (two-SNP haplotypes), 2) first intron SNPs Ϫ4,521 to Ϫ657, and 3) coding region/second intron SNPs ϩ45/ϩ276/ϩ349 (three-SNP haplotypes). The first intron haplotypes were not significantly associated with adiponectin in either whites or African Americans (global P Ͼ 0.2). We then explored the associations of the two-SNP and three-SNP haplotypes with adiponectin levels.
To test whether each haplotype was individually associated with adiponectin and whether haplotypes improved the model over simple SNP models, we compared the BIC values from various models. Table 3 shows that inclusion of three-SNP haplotypes improved the fit over the base (nongenetic) model in whites and African Americans. The two-SNP haplotype models were superior to the three-SNP haplotype models in whites but not African Americans. In whites and African Americans, models including the best additive SNPs significantly further improve the model fit over either the two-SNP or three-SNP haplotype models. Thus, the two-SNP and three-SNP haplotypes are somewhat important in explaining adiponectin level, but they are not superior to additive individual SNP models. Data are ␤ estimates Ϯ SE (g/ml). *Reference categories are boys and prepuberty. †Two-SNP haplotypes include Ϫ11,391/Ϫ10,068; three-SNP haplotypes include ϩ45/ϩ276/ϩ349; five-SNP haplotypes include Ϫ11,391/ Ϫ10,068/ϩ45/ϩ276/ϩ349. Each haplotype is modeled compared with all other haplotypes of the same type. ‡In African Americans, haplotypes G/G/G and G/G/G/G/G are moderately collinear (variance inflation factor Ϸ 5.0).
We then explored the combined effect of the two groups of haplotypes, either modeled independently as haplotypic interactions or as a noncontiguous five-SNP haplotype. Compared with the best additive SNP models, we found no improvement in model fit when including the two-SNP and three-SNP haplotypes as independent predictors. However, substantial improvement in the model fit was seen when interactions were modeled between the two-SNP and three-SNP haplotypes. Model fit further improved by modeling five-SNP noncontiguous haplotypes in African Americans but not in whites. Thus, individuals with specific haplotypes in both the promoter and coding region/ second intron of ACDC experience a greater impact on adiponectin levels than individuals with either haplotype alone. Table 4 presents the final best models, which include the five-SNP haplotypes in whites and African Americans.
To further explore the nonadditive relationship, we focused on the rare A/G/T/G/G haplotype in whites. Compared with individuals lacking the two-SNP A/G and the three-SNP T/G/G haplotypes (n ϭ 480), the T/G/G haplotype alone (n ϭ 36) did not alter adiponectin level (P ϭ 0.9), but the A/G haplotype alone (n ϭ 90) was associated with higher adiponectin (P ϭ 0.0006). Moreover, individuals with the A/G/T/G/G haplotype (n ϭ 6) had significantly higher levels than those with either the A/G (P ϭ 0.004) or the T/G/G (P ϭ 0.0008) haplotypes alone or with neither haplotype (P Ͻ 0.0001; Fig. 1 ).
DISCUSSION
Adiponectin levels have a strong genetic basis, and linkage studies have identified that the adiponectin locus ACDC on chromosome 3q27 contributes to phenotypic adiponectin levels. We therefore explored the association of specific SNPs and haplotypes within ACDC with phenotypic adiponectin levels in a biracial adolescent cohort.
We report that both promoter and coding region/second intron SNPs are associated with adiponectin level in non-Hispanic whites and African Americans. Consistent with the current study, several (16,17,28,36 -38) , but not all (30, 39) , studies have found the T allele of SNP ϩ276 associated with higher adiponectin. Higher adiponectin has previously been associated with the SNP Ϫ11,391 A allele in French whites (17, 40, 41) . Our results confirm this finding in whites and also replicate it among African Americans. We also report a novel association of the SNP Ϫ10,068 G allele with higher adiponectin levels in our white subset.
In addition, we report a novel within-gene interaction involving haplotypes in the promoter and coding region/ second intron of ACDC impacting the level of plasma adiponectin. Previous attempts to explore the relationships among ACDC SNPs in their association with adiponectin levels have yielded conflicting information. Although the T/G haplotype of SNPs ϩ45/ϩ276 is associated with lower plasma adiponectin level (16) , conditioning on the wild-type G allele at SNP Ϫ11,391 eliminated an association between SNPs ϩ45 or ϩ276 and adiponectin (17) . We also failed to find any association between the ϩ45/ϩ276/ϩ349 haplotype T/G/G and adiponectin level in those lacking the promoter Ϫ11,391/Ϫ10,068 A/G haplotype. However, whereas Vasseur et al. (17) explored the relationship among ACDC regions by subsetting on promoter-region genotype, we formally tested interactions between promoter and coding region/second intron haplotypes of ACDC. Because the strongest interactions were between the variant SNP Ϫ11,391 A allele and the ϩ45/ ϩ276/ϩ349 haplotype, we suspect that conditioning on the promoter-region wild-type Ϫ11,391 G allele would not reveal the interaction we report. Our analyses suggest that haplotypic associations with adiponectin may be dependent on the interaction between the promoter and coding region/second intron haplotypes, rather than the additive effects of each gene region alone.
To our knowledge, none of the SNPs included in the associated haplotypes is functional, although reports suggest that two of these SNPs may affect ACDC transcription. The SNP ϩ45 has been shown to have differential transcription from its two alleles (19) . However, the previous study reported higher transcription from the ϩ45 G allele, whereas we found higher plasma adiponectin levels among those carrying the T allele. In addition, although the SNP Ϫ11,391 does not disrupt a transcription factor binding site, it does lie near a putative region of gene regulation (17) . Further study will be necessary to determine the functional variants in the ACDC gene and the conditions under which variants in this gene may interact to alter adiponectin levels.
One way to explain nonlinear interactions between gene regions is functional SNPs acting in cis to affect ACDC gene expression. Although there are no other reports of interactions or cis effects within the ACDC gene, there is ample evidence that other genes, including those involved in the metabolic pathways of adiponectin, have cis-regulating elements and within-gene interactions that influence phenotypic gene expression (42, 43) . We could not directly test the relative importance of interaction (e.g., having both haplotype combinations) versus cis regulation (e.g., having both haplotype combinations on the same chromosome), either from a functional or an epidemiologic standpoint. However, the possibility for such cis relationships between the promoter and coding region/second intron of ACDC is consistent with our findings and should be explored further.
This study has several limitations. First, the frequencies for some of the SNPs and haplotypes most associated with adiponectin level were exceedingly small or nonexistent in African Americans, limiting our power. Furthermore, ge- notypes were not available for 16 and 6% of individuals for SNPs Ϫ12,823 and ϩ45, respectively. No race, sex, or adiposity differences were noted between typed and nontyped individuals (data not shown); however, missing data may reduce the power to detect differences by genotype. Second, although our data strongly supports a nonlinear interaction between the promoter and coding region/ second intron haplotypes, we cannot prove that our results are dependent on the cis organization of the variants, and further functional studies will be necessary to explore this issue. Third, we reported that the SNP ϩ45 is out of HWE in whites, and this may impact our findings. However, this finding may be due to chance, because after Bonferroni correction for the 11 SNPs tested, it is no longer significant. Finally, the relative contribution of these haplotypes is somewhat low, accounting for ϳ2-4% of the variance in adiponectin levels. Thus, although these haplotypes are significant independent predictors of adiponectin level, they should not be viewed as the primary determinants of it.
In summary, the current study provides novel data on the role of adiponectin gene ACDC SNPs in whites and African Americans, such that specific variants and haplotypes may interact to influence adiponectin levels. This analysis suggests that there is not a single SNP in ACDC responsible for modulating adiponectin levels. Rather, there may be multiple SNPs working in conjunction with each other and with the environment to influence adiponectin. More importantly, this interactive relationship is present in two racially distinct groups, suggesting a novel and complex genetic underpinning to adiponectin levels.
